Rabeprazole sodium
USP/1598019 - United States Pharmacopeia (USP) Reference Standard
Synonym: 2-
CAS Number: 117976-90-6
Empirical Formula (Hill Notation): C18H20N3O3S · Na
Molecular Weight: 381.42
Linear Formula: C18H20N3O3S · Na
Product Type: Chemical
API family | rabeprazole |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C18H20N3O3S.Na/c1-13-1 |
InChI key | KRCQSTCYZUOBHN-UHFFFAOYSA |
manufacturer/tradename | USP |
SMILES string | [Na+].COCCCOc1ccnc(CS(=O) |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Rabeprazole sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
Biochem/physiol Actions: | Rabeprazole sodium is gastric proton pump inhibitor. It suppresses the production of acid in the stomach by inhibiting the gastric H+/K+ATPase (hydrogen-potassium adenosine triphosphatase) at the secretory surface of the gastric parietal cell. Rabeprazole sodium has been used clinically to treat acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevent gastroinetestinal bleeds associated with NSAID use. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |